Predilife

PA:ALPRE France Diagnostics & Research
Market Cap
$12.59 Million
€12.27 Million EUR
Market Cap Rank
#32785 Global
#372 in France
Share Price
€3.13
Change (1 day)
-1.88%
52-Week Range
€2.96 - €4.29
All Time High
€15.90
About

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer pred… Read more

Predilife (ALPRE) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: 0.219x

Based on the latest financial reports, Predilife (ALPRE) has a cash flow conversion efficiency ratio of 0.219x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.28 Million) by net assets (€-5.82 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Predilife - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Predilife's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Predilife Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Predilife ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Predilife (2016–2024)

The table below shows the annual cash flow conversion efficiency of Predilife from 2016 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-4.27 Million €-3.72 Million 0.872x +110.59%
2023-12-31 €513.52K €-4.23 Million -8.236x -1502.63%
2022-12-31 €-5.22 Million €-3.07 Million 0.587x -75.98%
2021-12-31 €-1.57 Million €-3.83 Million 2.445x +183.67%
2020-12-31 €721.69K €-2.11 Million -2.922x -193.26%
2019-12-31 €-764.29K €-2.39 Million 3.133x -97.90%
2018-12-31 €-12.10K €-1.81 Million 149.479x +12560.50%
2017-12-31 €-1.29 Million €-1.53 Million 1.181x +131.59%
2016-12-31 €362.63K €-1.36 Million -3.737x --